• Explore /
  • Poster
  • / Phase I trial of the triplet veliparib + VX-970 + cisplatin in patients with advanced solid tumors.

Phase I trial of the triplet veliparib + VX-970 + cisplatin in patients with advanced solid tumors.

Abstract Poster

Authors

null

Geraldine Helen O'Sullivan Coyne

Early Clinical Trials Development Program, DCTD, National Cancer Institute at the National Institutes of Health, Bethesda, MD

Geraldine Helen O'Sullivan Coyne , Shivaani Kummar , Robert S. Meehan , Lamin Juwara , Richard Piekarz , Elad Sharon , Howard Streicher , Barbara A. Conley , Naoko Takebe , Lyndsay Harris , Austin Doyle , Mary Flanagan Quinn , Larry Rubinstein , Deborah Wilsker , Robert J. Kinders , Ralph E. Parchment , Elliot B Levy , James H. Doroshow , Alice P. Chen

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Clinical Pharmacology and Experimental Therapeutics

Track

Developmental Therapeutics and Translational Research

Sub Track

Other Novel Agents

Clinical Trial Registration Number

NCT02723864

Citation

J Clin Oncol 35, 2017 (suppl; abstr TPS2609)

DOI

10.1200/JCO.2017.35.15_suppl.TPS2609

Abstract #

TPS2609

Poster Bd #

94b

Abstract Disclosures

Similar Posters

First Author: Geraldine Helen O'Sullivan Coyne

First Author: Ryan Leibrandt

First Author: Bo Gao

First Author: Arjun Mittra